News | May 16, 2024
Cipla invests additional Rs. 26 crore in Achira
Achira is engaged in development and commercialization of PoC medical test kits in India
Achira is engaged in development and commercialization of PoC medical test kits in India
Outlook 2024 remains flat CER sales growth and CORE EBITDA margin of high 20s
EBITDA before special items falls 1.3 percent to € 4.41 billion
Investing considerably in production capacity for medical device packaging at its Rohrdorf and Halle sites in Germany
the campaign emphasizes the brand's reliability and effectiveness in providing timely relief
2024 full-year revenue guidance raised by US$ 2 billion
The joint venture will help JV Partners combine their strengths and grow their complementary nutraceuticals portfolios
Cellares will dedicate multiple Cell Shuttle and Cell Q systems with fully automated, high-throughput quality control for Bristol Myers Squibb’s exclusive use
Commercial terms include research funding and milestones and/or royalty payments to Evotec based on the success of the program
The newly issued patent, US Patent No. 11,957,647, provides both expanded scope of protection as well as longer patent term
Subscribe To Our Newsletter & Stay Updated
